Transient sampling of aggregation‐prone conformations causes pathogenic instability of a parkinsonian mutant of DJ‐1 at physiological temperature

Various missense mutations in the cytoprotective protein DJ‐1 cause rare forms of inherited parkinsonism. One mutation, M26I, diminishes DJ‐1 protein levels in the cell but does not result in large changes in the three‐dimensional structure or thermal stability of the protein. Therefore, the molecular defect that results in loss of M26I DJ‐1 protective function is unclear. Using NMR spectroscopy near physiological temperature, we found that the picosecond–nanosecond dynamics of wild‐type and M26I DJ‐1 are similar. In contrast, elevated amide hydrogen/deuterium exchange rates indicate that M26I DJ‐1 is more flexible than the wild‐type protein on longer timescales and that hydrophobic regions of M26I DJ‐1 are transiently exposed to solvent. Tryptophan fluorescence spectroscopy and thiol crosslinking analyzed by mass spectrometry also demonstrate that M26I DJ‐1 samples conformations that differ from the wild‐type protein at 37°C. These transiently sampled conformations are unstable and cause M26I DJ‐1 to aggregate in vitro at physiological temperature but not at lower temperatures. M26I DJ‐1 aggregation is correlated with pathogenicity, as the structurally similar but non‐pathogenic M26L mutation does not aggregate at 37°C. The onset of dynamically driven M26I DJ‐1 instability at physiological temperature resolves conflicting literature reports about the behavior of this disease‐associated mutant and illustrates the pitfalls of characterizing proteins exclusively at room temperature or below, as key aspects of their behavior may not be apparent.

[1]  Patrik Lundström,et al.  Local destabilization of the metal-binding region in human copper-zinc superoxide dismutase by remote mutations is a possible determinant for progression of ALS. , 2015, Biochemistry.

[2]  John A Tainer,et al.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes , 2014, Proceedings of the National Academy of Sciences.

[3]  Use of cysteine‐reactive cross‐linkers to probe conformational flexibility of human DJ‐1 demonstrates that Glu18 mutations are dimers , 2014, Journal of neurochemistry.

[4]  M. Repici,et al.  Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells , 2012, Journal of Molecular Medicine.

[5]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[6]  S. Englander,et al.  Protein dynamics viewed by hydrogen exchange , 2012, Protein science : a publication of the Protein Society.

[7]  S Walter Englander,et al.  Protein hydrogen exchange: Testing current models , 2012, Protein science : a publication of the Protein Society.

[8]  Vassilios Ioannidis,et al.  ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..

[9]  M. Wilson,et al.  Conservation of oxidative protein stabilization in an insect homologue of parkinsonism-associated protein DJ-1. , 2012, Biochemistry.

[10]  F. Regnier,et al.  Effect of Single Amino Acid Substitution on Oxidative Modifications of the Parkinson's Disease-Related Protein, DJ-1* , 2011, Molecular & Cellular Proteomics.

[11]  Shang-Te Danny Hsu,et al.  The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1. , 2011, Journal of molecular biology.

[12]  M. Lakshminarasimhan,et al.  Evolution of New Enzymatic Function by Structural Modulation of Cysteine Reactivity in Pseudomonas fluorescens Isocyanide Hydratase* , 2010, The Journal of Biological Chemistry.

[13]  S. Ray,et al.  Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease. , 2010, Biochemistry.

[14]  J. M. Sauder,et al.  Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. , 2010, Journal of molecular biology.

[15]  Julie D Forman-Kay,et al.  NMR evidence for differential phosphorylation‐dependent interactions in WT and ΔF508 CFTR , 2010, The EMBO journal.

[16]  D. Kern,et al.  Hidden alternate structures of proline isomerase essential for catalysis , 2010 .

[17]  L. Tibell,et al.  The ALS-associated mutation G93A in human copper-zinc superoxide dismutase selectively destabilizes the remote metal binding region. , 2009, Biochemistry.

[18]  Thilo Stehle,et al.  Oxidizable Residues Mediating Protein Stability and Cytoprotective Interaction of DJ-1 with Apoptosis Signal-regulating Kinase 1* , 2009, Journal of Biological Chemistry.

[19]  Mark A. Wilson,et al.  Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1* , 2009, Journal of Biological Chemistry.

[20]  D. Eliezer,et al.  Structural effects of Parkinson's disease linked DJ‐1 mutations , 2008, Protein science : a publication of the Protein Society.

[21]  A. Fink,et al.  Structural impact of three Parkinsonism-associated missense mutations on human DJ-1. , 2008, Biochemistry.

[22]  David S. Park,et al.  The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage , 2007, Proceedings of the National Academy of Sciences.

[23]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[24]  Jing Zhang,et al.  Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1*S , 2007, Molecular & Cellular Proteomics.

[25]  F. Regnier,et al.  Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease. , 2007, Biochemistry.

[26]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[27]  J. Hulleman Regulation of DJ-1 structure and function: Implications for Parkinson's disease , 2007 .

[28]  Jing Zhang,et al.  Identification of novel proteins associated with both alpha-synuclein and DJ-1. , 2007, Molecular & cellular proteomics : MCP.

[29]  T. Mak,et al.  DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 , 2006, Proceedings of the National Academy of Sciences.

[30]  Kexiang Xu,et al.  Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging , 2006, Proceedings of the National Academy of Sciences.

[31]  K. Xia,et al.  Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. , 2006, Human molecular genetics.

[32]  M. Cameron Sullards,et al.  Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.

[33]  Wenbo Zhou,et al.  DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T α-Synuclein Toxicity* , 2005, Journal of Biological Chemistry.

[34]  Paul Schanda,et al.  SOFAST-HMQC Experiments for Recording Two-dimensional Deteronuclear Correlation Spectra of Proteins within a Few Seconds , 2005, Journal of biomolecular NMR.

[35]  Steven P Gygi,et al.  The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. , 2005, Human molecular genetics.

[36]  David W. Miller,et al.  Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. , 2005, Brain research. Molecular brain research.

[37]  T. Mak,et al.  DJ-1, a novel regulator of the tumor suppressor PTEN. , 2005, Cancer cell.

[38]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[39]  Mark A. Wilson,et al.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Haass,et al.  Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1* , 2004, Journal of Biological Chemistry.

[41]  T. Hastings,et al.  Biomedicine. Parkinson's--divergent causes, convergent mechanisms. , 2004, Science.

[42]  N. Quinn,et al.  The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.

[43]  G. Petsko,et al.  The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. P. Loria,et al.  FAST-Modelfree: A program for rapid automated analysis of solution NMR spin-relaxation data , 2003, Journal of biomolecular NMR.

[45]  Dagmar Ringe,et al.  POVScript+: a program for model and data visualization using persistence of vision ray-tracing , 2003 .

[46]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[47]  A. Villaverde,et al.  Construction and deconstruction of bacterial inclusion bodies. , 2002, Journal of biotechnology.

[48]  A. Villaverde,et al.  Protein aggregation as bacterial inclusion bodies is reversible , 2001, FEBS letters.

[49]  A. Mitsumoto,et al.  DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin , 2001, Free radical research.

[50]  Joseph D. Kwasnoski,et al.  High-density miniaturized thermal shift assays as a general strategy for drug discovery. , 2001, Journal of biomolecular screening.

[51]  Rieko Ishima,et al.  Protein dynamics from NMR , 2000, Nature Structural Biology.

[52]  Joanne I. Yeh,et al.  A flash-annealing technique to improve diffraction limits and lower mosaicity in crystals of glycerol kinase. , 1998, Acta crystallographica. Section D, Biological crystallography.

[53]  P. V. van Zijl,et al.  Measurement of water–amide proton exchange rates in the denatured state of staphylococcal nuclease by a magnetization transfer technique , 1997, Proteins.

[54]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[55]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[56]  A. Bax,et al.  Rotational diffusion anisotropy of human ubiquitin from 15N NMR relaxation , 1995 .

[57]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[58]  A. Palmer,et al.  Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme. , 1995, Journal of molecular biology.

[59]  Bruce A. Johnson,et al.  NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.

[60]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[61]  S W Englander,et al.  Isotope effects in peptide group hydrogen exchange , 1993, Proteins.

[62]  A. Brünger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures , 1992, Nature.

[63]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[64]  P. Wright,et al.  Intramolecular motions of a zinc finger DNA-binding domain from Xfin characterized by proton-detected natural abundance carbon-13 heteronuclear NMR spectroscopy , 1991 .

[65]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[66]  R K Scopes,et al.  Measurement of protein by spectrophotometry at 205 nm. , 1974, Analytical biochemistry.

[67]  Yawen Bai,et al.  Primary structure effects on peptide group hydrogen exchange , 1993, Biochemistry.

[68]  P. K. Glasoe,et al.  USE OF GLASS ELECTRODES TO MEASURE ACIDITIES IN DEUTERIUM OXIDE1,2 , 1960 .